In the latest instalment of 'Meet the Maker' EPM talks to Wayne Camarco, sales manager - UK, Ireland and Scandinavia at integrated manufacturing company ACG. Wayne talks Brexit, his average day and how people are becoming more conscious of the environment.
MarcoOne
Could you give us a brief description of yourself?
I have 30 years of global pharmaceutical and healthcare experience, with most of my roles in R&D and technical management. This culminated in technical sales and business development.
Please describe your average day in five words.
Science, client interaction, building loyalty
At what point did you decide to be involved in the pharma market?
From a very young age I have been fascinated by biology and my interest has never waned! At the very beginning of my career I wanted to get into pharma because I could see the industry was full of interesting opportunities and it would be an exciting path to pursue. The science behind the business is what I find really interesting, especially pharma formulation and drug delivery. I made the move while I was in the US and transferred from a specialty chemicals role by asking the CEO (who was touring our plant) for an internal transfer to a pharma group.
What has been your biggest achievement?
I believe moving countries between the UK, US and France over my career has been my biggest achievement and has presented many challenges along the way. Although it has involved a lot of work with many transformations, it has helped not only with career experience, but also gaining cultural and life experience, and developing a good number of lasting friendships.
What would you say is your worst trait?
Sometimes I can get a bit too detail-orientated for tasks better delegated to our internal experts.
What do you love about your job?
I love interacting with customers and our internal team. Regularly meeting customers to help them in their business is one of the best parts of working at ACG. We as the ACG group supply not only capsules, but the associated machinery for capsules production, such as encapsulation machines, films and foils and inspection equipment, which is exciting to be able to offer.
If anything, what would you change about your job?
There’s always so much going on in the industry, so finding more time to read articles and journals would be welcome.
If you weren’t in the pharma industry what job would you like to do?
Medical doctor.
What challenges do you foresee being important over the next 10 years?
In the short-term, Brexit! Resolving and reacting to the logistical and regulatory challenges with the change may keep us busy.
“Clean” labelling is also important for the future. The rising trend for veganism and vegetarianism is evidence of how people are becoming more conscious of their impact on the environment. The pharma and nutraceutical industry will be questioned more as to the ingredients they use and also their environmental impact.
In your opinion, what will offer the biggest opportunities in the future?
From the technical side there will be more opportunities in biochemistry instead of regular, “small molecule” traditional chemistry, and thus more specialised R+D into biological drugs and their effective delivery.
There will always be a market for oral delivery dosage forms and ACG has a new technical products coming out as we strive to be at the forefront to assist future pharma innovations. As we are a supplier of end-to-end manufacturing solutions for pharmaceutical and nutraceutical manufacturers of tablet and capsule based products, there will always be many exciting opportunities happening in scientific and manufacturing developments.